Downgrade: HOLD / BUY / BUY → HOLD / HOLD / HOLD. Celsius missed Q2 (filed 6 Aug): revenue $817.9m, +10.6% YoY but ~$55m light of ~$870m consensus — the first miss in five quarters — and the flagship Celsius brand fell ~12%, with growth now carried by Alani Nu (+56%) and Rockstar. Gross margin compressed 51.5%→48.1% and operating income halved; the stock gapped −19.2% to $23.77, a 16-month low, on 4.4× volume. The medium- and long-term BUYs are withdrawn: the core engine has turned negative, so Quality drops High→Medium and the name is now a value-trap-risk HOLD despite a cheaper price.
Celsius Holdings is a functional-beverage company built around fitness-and-health energy drinks. Its core business is developing and marketing branded, sugar-free energy drinks and powders — the flagship CELSIUS line plus the acquired Alani Nu and Rockstar brands — and getting them onto shelves through PepsiCo's US direct-store-delivery network and, internationally, through Suntory. What distinguishes it is a portfolio position as the clear US #2 in energy drinks (roughly a fifth of the category) skewed to younger, health-conscious consumers, and an asset-light model: it owns the brands and formulas but outsources bottling and distribution, which lets it run high gross margins and strong free-cash-flow conversion. For a reader, think of it as a brand-and-marketing company in a fast-moving consumer category, riding the shift from sugary sodas to functional drinks — now wrestling with a maturing flagship brand and intensifying competition.
Lifecycle & sector: classified Consumer Staples (Beverages — Non-Alcoholic), but behaves like a decelerating growth beverage. Total Q2 revenue grew +10.6% YoY to $817.9m — but that is now acquisition-carried: the flagship Celsius brand fell ~12% YoY, offset by Alani Nu (+56% retail) and the completed Rockstar integration. Organic momentum in the core engine has turned negative — the single most important change this quarter and the reason Quality drops from High to Medium.
| Sub-signal | Reading | Score | Rationale |
|---|---|---|---|
| Revenue trajectory | Total +10.6% YoY; core brand −12%; first revenue miss in 5 quarters (~$55m light vs ~$870m consensus) | 50 | Headline growth still positive but organic core shrinking — quality of growth deteriorating |
| Profitability / margins | Gross margin 48.1% (was 51.5% a year ago, −340bps); operating margin 9.2% vs 19.3%; operating income halved to $75.3m | 48 | Material margin compression (mix, promo, integration costs) |
| Cash generation | TTM FCF ~$0.53bn; FCF/EV ~8.7%; OCF/sales 19% | 78 | Genuine strength — asset-light model converts well (aided by D&A, SBC add-back and working-capital timing; conversion > net income) |
| Balance-sheet health | Net-debt-neutral (cash ~$0.6bn ≈ debt); interest coverage 4.4×; current ratio 1.8; D/E 0.56 | 75 | Sound — the prior 'elevated leverage' caution is overstated on current data |
Moat score 48/100 (was 52) — brand is the only real wall, and it is being tested.
| Competitor | Threat type | Share trajectory vs CELH | Moat-erosion vector |
|---|---|---|---|
| Monster Beverage (MNST) | Direct #1 US rival (~27% share) | CELH core losing; Monster stable | Shelf/scale; Monster's own launches |
| Red Bull (private) | Global #1 | Stable / holding | Brand + on-premise dominance |
| Keurig Dr Pepper / Ghost (KDP) | Well-funded challenger brand | Ghost gaining | KDP distribution muscle behind a youth brand |
| Costco Kirkland Signature energy | Low-cost private label (launched Mar 2026) | Taking value-seeking volume | Price undercut; pressures pricing power |
| Poppi / Olipop / PepsiCo prebiotics | Adjacent 'functional/health' substitution | Winning 'health' occasions | Steals the wellness positioning CELSIUS relied on |
| GLP-1 weight-loss drugs | Structural demand headwind | Category-wide | Lower appetite/consumption occasions (contested magnitude) |
Net effect on the moat: Switching Costs trimmed to 30 and Cost Advantage to 48; the flagship's ~12% decline is direct evidence of share/relevance loss even as Alani Nu offsets it. Competitive threat level: HIGH (raised from elevated); combined US share roughly stable only because Alani is masking the core decline.
ROIC & capital allocation: ROIC is depressed by goodwill from the Alani/Rockstar deals; FMP scores ROE 3/5, ROA 2/5. Capital allocation is a swing factor — the acquisitions bought scale and offset a weakening core, but at the cost of dilution and integration margin drag. Management skin-in-the-game: founder-led (CEO John Fieldly), moderate insider alignment.
The −19% gap-down did the valuation work: at $23.77 the stock trades at roughly 15× forward adjusted EPS (FY26 consensus ~$1.55–$1.65, which will be trimmed after the miss) and ~13× FY27 — versus the ~7,330%-run peak that once carried 100×+.
| Lens | Reading | Interpretation |
|---|---|---|
| Forward P/E (FY26 adj.) | ~15× (~13× FY27) | Attractive for a 20%-share, 48%-GM brand — if estimates hold |
| FCF yield (FCF/EV) | ~8.7% | Very attractive universal anchor |
| Trailing GAAP P/E | ~113×; P/B 5.0×; P/S 2.0× | Expensive on trailing GAAP — trough/transition-year artifact; FMP P/E & P/B sub-scores both 1/5 |
| Own-history decile | Bottom of its multi-year range | Cheapest it has traded as a public growth name |
| FMP health rating | B− (overall 2/5; DCF 5/5) | Downgraded from 3/5; DCF still says undervalued on cash flows |
CELSIUS is a premium, impulse-purchase beverage, so its dominant external driver is consumer spending power and the growth of the functional-energy category, moderated by competitive intensity. The two pull in opposite directions right now.
| Horizon | Read | Detail |
|---|---|---|
| Historical (12–24m) | Neutral | Category grew mid-single digits; CELH rode it hard, then decelerated as competition and its own base caught up |
| Current | Neutral/soft | Consumer cooling in a stagflation-lite regime (soft July payrolls, ~$90 Brent); category still growing but CELH core losing share — company execution is the binding constraint, not the category |
| Forward (6–12m) | Neutral | Functional-beverage TAM ~8% CAGR is a tailwind; GLP-1 + private-label + prebiotic substitution are offsets |
Driver score 50 (Neutral) → not eligible to amplify (needs ≥65 to lift a BUY or ≤35 to deepen a SELL). It leaves the base signal unchanged. Thesis-invalidation floor: the case breaks if the core Celsius brand decline accelerates beyond this quarter's −12% and combined US share slips — that is the dial to watch, and it is already amber.
The latest MacroDriver report (30 Jul 2026, 'stagflation-lite — energy shock re-armed') scores Consumer Staples (XLP) Outperform short/medium, Neutral long — a mild sector tailwind. But CELH is a premium, discretionary-consumption growth beverage, not a defensive staple, so the staples signal does not cleanly transfer; a cooling consumer is a mild offset. Net pressure Neutral, conviction 50 — no amplification either way. The macro report's armed 'S&P 500 concentration / AI unwind' tail does NOT apply (CELH is not an AI-cohort name); it is not inherited into the bear case.
Source: sector-map (XLP) · Macro report 2026-07-30
Multi-timeframe confluence is strongly bearish: monthly and weekly downtrends, daily strong downtrend, all below the 50- and 200-day. The Q2 miss produced a capitulation-type flush — −19% on 4.4× average volume to a 16-month low. Daily RSI 31, hourly 28 (oversold); the 15-min turned 'recovering', hinting at a dead-cat/relief bounce, but there is no confirmed reversal and no reclaim of the $29.5 50-day.
| Signal | Reading | Read |
|---|---|---|
| Risk-reward | Stop below $23.55; ATR(d) $1.71 | Oversold but knife-catch risk |
| Relative strength | −39% YTD; deeply lagging SPY & XLP | Laggard |
| Macro overlay | Fed on hold; VIX ~16; XLP in favour | Mildly supportive backdrop |
| Sentiment | News tone strongly negative post-miss; grades pre-crash maintains (cuts pending) | Negative |
| Catalyst density | Big event (earnings) just cleared; calendar calm 30d | Path risk lower now |
Timing 36 (Weak). A short-term BUY would require the Technical or Catalyst group to confirm — neither has; buy only on a confirmed reclaim of the 50-day or a tested higher-low off support.
| Date | Event | Impact | Forecast | Previous | Relevant? | Why |
|---|---|---|---|---|---|---|
| 2026-08-07 | Nonfarm Payrolls / Unemployment (Jul) | High | 80k / 4.2% | 57k / 4.2% | ⚠ Indirect | Consumer-health read for a discretionary beverage |
| 2026-08-11 | NFIB / Existing Home Sales | Low–Med | — | — | No | Not CELH-specific |
| ~2026-11 | CELH Q3 2026 earnings | High | — | — | ✅ Yes | Next test of whether the core brand stabilises |
| Date | Event | Actual | Forecast | Surprise | Impact |
|---|---|---|---|---|---|
| 2026-08-06 | Challenger Job Cuts (Jul) | 33.4k | 59k | below (fewer cuts) | Mildly risk-on |
| 2026-08-06 | Nonfarm Productivity (Q2) | 1.4% | 0.6% | above | Disinflationary, mildly supportive |
| 2026-08-06 | Initial Jobless Claims | 199k | 202k | below | Labour still firm |
CELH has low direct macro sensitivity — the dominant variable is company execution, not the calendar. The only relevant macro thread is the health of the discretionary consumer (July payrolls today); a sharply weaker consumer would compound the core-brand problem. No high-impact, CELH-specific dated event sits in the next fortnight now that Q2 has cleared.
| Timeframe | Trend | Direction | RSI | MACD | Key S/R | Breakout | Vol |
|---|---|---|---|---|---|---|---|
| Monthly | Downtrend | Bearish | 39 | −, falling | S 21.1 / R 40.8 | Support breakdown | 0.5x |
| Weekly | Downtrend | Bearish | 35 | −, falling | S 27.5 / R 47.7 | Support breakdown | 1.8x |
| Daily | Strong downtrend | Bearish | 31 | −, falling | S 26.5 / R 29.6 (50d) | Support breakdown | 4.4x |
| Hourly | Strong downtrend | Bearish | 28 | −, base? | S 23.6 / R 28.5 | Support breakdown | — |
| 15-min | Recovering | Neutral | 48 | + turning | S 23.6 / R 24.7 | Minor breakout | 0.2x |
| Confluence: Strongly Bearish · MTF Score 22 | |||||||
Every higher timeframe is in a confirmed downtrend and price broke support on huge post-earnings volume. The only green shoot is the 15-min 'recovering' with oversold daily/hourly RSI — setup for a relief bounce, not a trend change. The level that matters: a daily reclaim of the 50-day (~$29.6) on volume would be the first sign the bleeding has stopped; below $23.55 opens the door to the low-$20s / $21 monthly support.
6-month daily close. The February ~$54 high gave way to a steady bleed through spring/summer; the 6 Aug earnings miss produced a −19% gap to a 16-month low at $23.77 on 4.4× volume.
Core Celsius brand stabilises within a couple of quarters; Alani Nu (+56%) and international keep total growth low-double-digit; gross margin recovers toward 50%+ as integration costs roll off; estimates stop falling and the stock re-rates to ~19–20× forward. A PepsiCo takeout would land in this zone or above. ~+51% from $23.77.
Choppy stabilisation: total growth stays high-single/low-double-digit on acquisitions while the core brand remains soft; margins hold ~48%; consensus is trimmed modestly and the stock grinds at ~15–17× forward. The most probable centre of gravity — cheap but no catalyst to re-rate until the core turns. ~+14%.
Competitive trigger: Costco Kirkland private label, KDP-Ghost and Monster take further share as the core Celsius decline accelerates beyond −12% and combined US share slips below ~18%; GLP-1 pressure and further margin compression drive another leg of estimate cuts; the multiple de-rates to ~11–12×, compounded by the Texas-AG / securities legal overhang. ~−24%.
Forecast: Fundamental group is already met (price below fair value) — which sets a HALF-SIZE ceiling on conviction, not permission to chase. Technical group: UNLIKELY in the next 4–6 weeks — a reclaim of the ~$29.6 50-day is ~24% above spot and the trend is down; a tested higher-low off $23.5–$24 support is the more reachable early trigger (watch for it on the relief bounce). Catalyst group: not until Q3 earnings (~Nov) shows whether the core brand stabilises — that is the real re-rating gate. Confidence: Moderate the fundamental cheapness persists; Low that the technical confirms soon.
Forecast: Stop is ~1% below spot — a real near-term risk if the relief bounce fails; two closes under $23.55 would flip the action to EXIT. Thesis-invalidation is the one to watch at Q3: a second double-digit core decline confirms structural share loss and would be an exit regardless of price.
What you're risking: you would be catching a knife — every higher timeframe is in a downtrend, the Technical entry group is unmet, and estimates have not finished being cut. The hard stop sits just ~1% below at $23.55; a failed relief bounce puts $21 (monthly support) in play. The core brand is shrinking and the legal overhang is live.
What you're gaining: a genuinely cheaper entry — ~15× forward earnings and ~8.7% FCF yield on the US #2 energy brand, with Alani Nu still +56%, PepsiCo takeout optionality, and international un-modelled. You start collecting the base-case ~14% and own the free upside.
Read: waiting materially improves the deal — a tested higher-low off support (or Q3 evidence the core has stabilised) removes most of the knife-catch risk for little given-up upside. Half-size at most if acting; the entry edge is fundamental-only.
What you're giving up: selling here locks in the loss near a 16-month low, at ~15× forward and below the ~$27 probability-weighted fair value — you would be crystallising the disappointment at the point of maximum pessimism, forfeiting the Alani/international optionality and any takeout.
What you're protecting: capital, if the core decline accelerates — and no exit rule is mechanically triggered right now (stop not hit, no profit target, thesis not yet 2-of-N broken).
Read: no mechanical reason to force a sale today; this is a HOLD/monitor zone. The decision rule is at Q3 — stabilising core = hold/accumulate; a second double-digit core drop = exit.
Position sizing not computed — specify your portfolio allocation and role for sizing guidance.
{
"ticker": "CELH",
"date": "2026-08-07",
"version": "v6",
"company": "Celsius Holdings, Inc.",
"brand": "Celsius",
"currency": "USD",
"exchange": "NASDAQ",
"exchange_ticker": "NASDAQ:CELH",
"isin": "US15118V2079",
"api_ticker": "CELH",
"analysis_status": "on-going",
"lifecycle_stage": "growth-decelerating",
"sector": "Consumer Staples",
"gics_sector": "Consumer Staples",
"country": "United States",
"price_at_rating": 23.77,
"signal_short": "HOLD",
"signal_medium": "HOLD",
"signal_long": "HOLD",
"primary_signal": "HOLD",
"short_hold_reason": "weak_timing",
"quality_score": 61,
"valuation_score": 65,
"timing_score": 36,
"driver_score": 50,
"economic_alignment_stance": "Neutral",
"economic_alignment_conviction": 50,
"economic_alignment_pressure": "Neutral",
"economic_alignment_source": "sector-map",
"macro_report_date": "2026-07-30",
"overall_confidence": 55,
"val_band": "attractive",
"val_multiple_basis": "forward adjusted P/E (FY26 est ~$1.6)",
"warranted_multiple": 17.8,
"actual_multiple": 15.0,
"warranted_ratio": 0.84,
"discount_rate_r": 10.13,
"risk_free_10y": 4.63,
"g_near": 8,
"g_term": 3,
"clean_pe": 15.0,
"clean_peg": 1.0,
"nonop_pct_of_net_income": -8,
"fcf_yield": 8.7,
"fair_value_est": 27,
"stop_loss": 23.55,
"target_price": 27,
"scenario_base_target": 27,
"scenario_bull_target": 36,
"scenario_bear_target": 18,
"entry_groups_met": 1,
"entry_conviction": "Half-Size",
"exit_groups_live": 0,
"exit_action": "Hold",
"hard_gate_state": "caution",
"gates_triggered": [],
"gates_caution": [
"Acquisition share dilution +9% YoY (one-time Alani/Rockstar stock consideration)",
"Texas-AG caffeine-marketing investigation + Pomerantz securities investigation (legal overhang)",
"HIGH competitive threat (Monster, Red Bull, KDP-Ghost, Costco Kirkland private label, prebiotics, GLP-1)"
],
"do_not_buy_triggers": [],
"short_entry_confirmed": false,
"short_cap_reason": "Short base HOLD from Weak timing (strong downtrend, no 50-day reclaim); Technical & Catalyst entry groups both unmet. Quality-starter override does NOT fire (medium & long are HOLD, not BUY).",
"competitive_share_trajectory": "stable",
"competitive_threat_level": "high",
"analyst_consensus_target": 47.67,
"analyst_target_high": 57,
"analyst_target_low": 26,
"analyst_target_upside_pct": 100.5,
"analyst_target_note": "STALE (pre-6 Aug crash); freshest last-month avg $42; expect cuts",
"analyst_grades_consensus": "Buy",
"analyst_bullish_pct": 96,
"analyst_coverage_count": 29,
"recent_upgrades_30d": 0,
"recent_downgrades_30d": 0,
"fmp_rating": "B-",
"fmp_overall_score": 2,
"relative_strength_vs_spy": -39,
"relative_strength_vs_sector": -35,
"catalyst_clustering_score": 60,
"mtf_confluence": 22,
"industry_benchmark_name": "Beverage composite (gross margin + volume/share growth)",
"industry_benchmark_value": "GM 48.1% + core brand volume -12%",
"industry_benchmark_score": 58,
"moat_score": 48,
"roic_percentile_vs_peers": 45,
"user_horizon": null,
"user_allocation_pct": null,
"portfolio_role": null,
"next_update_date": "2026-08-21",
"next_update_basis": "default +14d (Q2 earnings reported 6 Aug; no impactful dated event in window)",
"ai_concentration_tail_inherited": false,
"prior_report": "calibration-CELH-20260720-1900.json",
"prior_primary": "BUY",
"changes_note": "DOWNGRADE HOLD/BUY/BUY -> HOLD/HOLD/HOLD after Q2 miss (filed 6 Aug). Core Celsius brand sales -12% YoY; total rev +10.6% (first miss in 5 quarters, ~$55m light); GM 51.5%->48.1%, op income halved; stock -19.2% to $23.77 (16-mo low, 4.4x vol). Quality 66->61 (High->Medium, organic core turned negative). Valuation 65->65 (crash offsets estimate cuts; attractive-edge). Timing 46->36. Driver 54->50. Econ Trend-Following/55 -> Neutral/50. No new gates/DNB. Entry Half-Size unchanged."
}
Signal HOLD across all three horizons — a downgrade from HOLD / BUY / BUY. Quality falls High→Medium (61) on the core-brand −12% and margin compression; Valuation stays attractive-edge (65) as the −19% crash offsets estimate cuts; Timing weakens to 36 on the strong downtrend. No hard gate or DNB fires. Entry conviction Half-Size (Fundamental group only). This is a genuine thesis-damage downgrade, not a tape wobble: the flagship brand is shrinking and the reward will not skew up until the core stabilises — revisit at Q3.